310.

Dettmar PW, Smith AW. Pharmaceutical compositions containing triclosan or derivatives thereof and EDTA or EGTA. PCT Int. Appl. WO 96 00,569 (Cl. A61K31/195), 11 Jan 1996, GB Appl. 94/13,072, 29 Jun 1994; 27 pp. (CA) [A pharmaceutical compn. in oral unit dosage form for the treatment of gastrointestinal disorders assocd. with Helicobacter pylori infections comprises 0.1-300 mg triclosan or a deriv. thereof and 1-600 mg of EDTA or a salt thereof, or 1-3600 mg of EDTA or a salt thereof, the wt. ratio of triclosan to the EDTA in each unit being in the range of 1:(2-60), or the wt. ratio of triclosan to the EGTA in each unit being in the range of 1:(10-500). For example, a tablet contained triclosan 15, Na2EDTA2H2O 76.5, CaCO3 100, microcryst. cellulose 270.5, Mg stearate 3, and NaHCO3 20 mg.]

Gordon Research Institute / Reference Material

Gordon Research Institute    Dr. Garry F. Gordon MD DO MD(H)
600 N Beeline Hwy, Suite B, Payson, AZ 85541
Phone: 928-472-4263    Fax: 928-474-3819
Email Dr.Gordon